Institute for Clinical and Translational Research

Profiles



Video Tutorials
Keywords
Last Name
Institution

JAMES L POOL

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Hypertension
Address1977 Butler Boulevard
HOUSTON TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Pharmacology and Chemical Biology
    DivisionPharmacology


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Taylor AA, Pool JL. Clinical role of direct renin inhibition in hypertension. Am J Ther. 2012 May; 19(3):204-10. PMID: 21317620.
      View in: PubMed
    2. Perlstein TS, Henry RR, Mather KJ, Rickels MR, Abate NI, Grundy SM, Mai Y, Albu JB, Marks JB, Pool JL, Creager MA. Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose. Clin Sci (Lond). 2012 Feb; 122(4):193-202. PMID: 21861845; PMCID: PMC4566948.
      View in: PubMed, PubMed Central
    3. Hyman DJ, Pavlik VN, Greisinger AJ, Chan W, Bayona J, Mansyur C, Simms V, Pool J. Effect of a physician uncertainty reduction intervention on blood pressure in uncontrolled hypertensives--a cluster randomized trial. J Gen Intern Med. 2012 Apr; 27(4):413-9. PMID: 22033742; PMCID: PMC3304039.
      View in: PubMed, PubMed Central
    4. Ferdinand KC, Pool J, Weitzman R, Purkayastha D, Townsend R. Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial. J Clin Hypertens (Greenwich). 2011 May; 13(5):366-75. PMID: 21545398.
      View in: PubMed
    5. Friedewald VE, Bennett JS, Christo JP, Pool JL, Scheiman JM, Simon LS, Strand V, White WB, Williams GW, Roberts WC. AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. Am J Cardiol. 2010 Sep 15; 106(6):873-84. PMID: 20816131.
      View in: PubMed
    6. Pavlik VN, Greisinger AJ, Pool J, Haidet P, Hyman DJ. Does reducing physician uncertainty improve hypertension control?: rationale and methods. Circ Cardiovasc Qual Outcomes. 2009 May; 2(3):257-63. PMID: 20031846; PMCID: PMC2780342.
      View in: PubMed, PubMed Central
    7. Pool JL, Glazer R, Crikelair N, Levy D. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial. Clin Drug Investig. 2009; 29(12):791-802. PMID: 19888785.
      View in: PubMed
    8. Friedewald VE, Giles TD, Pool JL, Yancy CW, Roberts WC. The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease. Am J Cardiol. 2008 Aug 15; 102(4):418-23. PMID: 18678298.
      View in: PubMed
    9. Oparil S, Abate N, Chen E, Creager MA, Galet V, Jia G, Julius S, Lerman A, Lyle PA, Pool J, Tershakovec AM. A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension. Curr Med Res Opin. 2008 Apr; 24(4):1101-14. PMID: 18328120.
      View in: PubMed
    10. Pool JL. Direct renin inhibition: focus on aliskiren. J Manag Care Pharm. 2007 Oct; 13(8 Suppl B):21-33. PMID: 17970614.
      View in: PubMed
    11. Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Am J Hypertens. 2007 Jan; 20(1):11-20. PMID: 17198906.
      View in: PubMed
    12. Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Clin Ther. 2007 Jan; 29(1):61-73. PMID: 17379047.
      View in: PubMed
    13. Friedewald VE, Jones PH, Kaplan NM, Pool JL, Roberts WC. The editor's roundtable: concurrent hypertension and dyslipidemia. Am J Cardiol. 2007 Jan 1; 99(1):134-44. PMID: 17196477.
      View in: PubMed
    14. Wieles B, Pool J, Wilke M, Weber M, Kolb HJ, Bontrop RE, Goulmy E. The diallelic locus encoding the minor histocompatibility antigen HA-1 is evolutionarily conserved. Tissue Antigens. 2006 Jul; 68(1):62-5. PMID: 16774541.
      View in: PubMed
    15. Taylor AA, Pool JL. Clinical pharmacology of antihypertensive therapy. Semin Nephrol. 2005 Jul; 25(4):215-26. PMID: 16202694.
      View in: PubMed
    16. Pool JL. Is it time to move to multidrug combinations? Am J Hypertens. 2003 Nov; 16(11 Pt 2):36S-40S. PMID: 14625159.
      View in: PubMed
    17. Pool J, Kaihlanen P, Lewis G, Ginsberg D, Oparil S, Glazer R, Messerli FH. Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone. J Hum Hypertens. 2001 Jul; 15(7):495-8. PMID: 11464260.
      View in: PubMed
    18. Kloner RA, Weinberger M, Pool JL, Chrysant SG, Prasad R, Harris SM, Zyczynski TM, Leidy NK, Michelson EL. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol. 2001 Mar 15; 87(6):727-31. PMID: 11249891.
      View in: PubMed
    19. Pool JL, Kirby RS. Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia. Int Urol Nephrol. 2001; 33(3):407-12. PMID: 12230262.
      View in: PubMed
    20. Kirby RS, Pool JL. Interpretation of the ALLHAT interim analysis and implications for the treatment of patients with BPH. Prostate Cancer Prostatic Dis. 2000 Nov; 3(3):152-156. PMID: 12497091.
      View in: PubMed
    21. Pool JL. The role of angiotensin II in hypertension and end-organ damage. Int J Clin Pract Suppl. 2000 Aug; (111):4-8. PMID: 15977400.
      View in: PubMed
    22. Sica DA, Pool JL. Current Concepts of Pharmacotherapy in Hypertension - Alpha-Adrenergic Blocking Drugs: Evolving Role in Clinical Medicine. J Clin Hypertens (Greenwich). 2000 Mar; 2(2):138-142. PMID: 11416638.
      View in: PubMed
    23. Taylor AA, Shepherd AM, Polvino W, Mangoo-Karim R, Ballard K, Sunthornyothin S, Luther RR, Pool JL. Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects. Am J Hypertens. 1999 Sep; 12(9 Pt 1):906-14. PMID: 10509549.
      View in: PubMed
    24. Taylor AA, Mangoo-Karim R, Ballard KD, Luther RR, Pool JL. Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study. J Clin Pharmacol. 1999 May; 39(5):471-9. PMID: 10234594.
      View in: PubMed
    25. Pool JL, Glazer R, Chiang YT, Gatlin M. Dose-response efficacy of valsartan, a new angiotensin II receptor blocker. J Hum Hypertens. 1999 Apr; 13(4):275-81. PMID: 10333347.
      View in: PubMed
    26. Jenkins CD, Miller TQ, Hewitt LO, Wallace JM, Pool JL. A 3-dimensional analysis of modes of cardiovascular adaptation: concepts, methods and preliminary findings. Clin Invest Med. 1998 Dec; 21(6):228-50. PMID: 9885758.
      View in: PubMed
    27. Pool J, Oparil S, Hedner T, Glazer R, Oddou-Stock P, Hester A. Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker. Clin Ther. 1998 Nov-Dec; 20(6):1106-14. PMID: 9916605.
      View in: PubMed
    28. Lacourcière Y, Pool JL, Svetkey L, Gradman AH, Larochelle P, de Champlain J, Smith WB. A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group. Am J Hypertens. 1998 Apr; 11(4 Pt 1):454-61. PMID: 9607384.
      View in: PubMed
    29. Pool JL, Guthrie RM, Littlejohn TW, Raskin P, Shephard AM, Weber MA, Weir MR, Wilson TW, Wright J, Kassler-Taub KB, Reeves RA. Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension. Am J Hypertens. 1998 Apr; 11(4 Pt 1):462-70. PMID: 9607385.
      View in: PubMed
    30. Kirby RS, Pool JL. Alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia: past, present and future. Br J Urol. 1997 Oct; 80(4):521-32. PMID: 9352686.
      View in: PubMed
    31. Neutel J, Weber M, Pool J, Smith D, Fitzsimmons S, Chiang YT, Gatlin M. Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours. Clin Ther. 1997 May-Jun; 19(3):447-58; discussion 367-8. PMID: 9220209.
      View in: PubMed
    32. Pool JL, Cushman WC, Saini RK, Nwachuku CE, Battikha JP. Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension. Am J Hypertens. 1997 Jan; 10(1):117-23. PMID: 9008256.
      View in: PubMed
    33. Pool JL. Doxazosin: a new approach to hypertension and benign prostatic hyperplasia. Br J Clin Pract. 1996 Apr-May; 50(3):154-63. PMID: 8733335.
      View in: PubMed
    34. Lenz ML, Pool JL, Laddu AR, Varghese A, Johnston W, Taylor AA. Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions. Am J Hypertens. 1995 Feb; 8(2):133-45. PMID: 7755941.
      View in: PubMed
    35. Bradford RH, Shear CL, Chremos AN, Dujovne CA, Franklin FA, Grillo RB, Higgins J, Langendorfer A, Nash DT, Pool JL, et al. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Am J Cardiol. 1994 Oct 1; 74(7):667-73. PMID: 7942524.
      View in: PubMed
    36. Pool JL. Role of the sympathetic nervous system in hypertension and benign prostatic hyperplasia. Br J Clin Pract Suppl. 1994 May; 74:13-7. PMID: 7519436.
      View in: PubMed
    37. Pool JL. Effects of doxazosin on coronary heart disease risk factors in the hypertensive patient. Br J Clin Pract Suppl. 1994 May; 74:8-12. PMID: 8049119.
      View in: PubMed
    38. Ciampricotti R, Deckers JW, Taverne R, el Gamal M, Relik-van Wely L, Pool J. Characteristics of conditioned and sedentary men with acute coronary syndromes. Am J Cardiol. 1994 Feb 1; 73(4):219-22. PMID: 8296749.
      View in: PubMed
    39. Black HR, Chrysant SG, Curry CL, Frishman WH, Grimm RH, Lasseter KC, Okun R, Pool JL, Raizada V, Vlachakis ND, et al. Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension. J Clin Pharmacol. 1992 Apr; 32(4):351-9. PMID: 1349028.
      View in: PubMed
    40. Pool JL, Shear CL, Downton M, Schnaper H, Stinnett S, Dujovne C, Bradford RH, Chremos AN. Lovastatin and coadministered antihypertensive/cardiovascular agents. Hypertension. 1992 Mar; 19(3):242-8. PMID: 1347757.
      View in: PubMed
    41. Pool JL. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials. Am Heart J. 1991 Sep; 122(3 Pt 2):926-31. PMID: 1678924.
      View in: PubMed
    42. Bradford RH, Shear CL, Chremos AN, Franklin FA, Nash DT, Hurley DP, Dujovne CA, Pool JL, Schnaper H, Hesney M, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. Am J Med. 1991 Jul 31; 91(1B):18S-24S. PMID: 1867232.
      View in: PubMed
    43. Dujovne CA, Chremos AN, Pool JL, Schnaper H, Bradford RH, Shear CL, Higgins J, Downton M, Franklin FA, Nash DT, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin. Am J Med. 1991 Jul 31; 91(1B):25S-30S. PMID: 1831006.
      View in: PubMed
    44. Weir MR, Josselson J, Ekelund LG, Korc M, Pool JL, Stein GH, Wolbach RA, Champion D. Nicardipine as antihypertensive monotherapy: positive effects on quality of life. J Hum Hypertens. 1991 Jun; 5(3):205-13. PMID: 1920344.
      View in: PubMed
    45. Pool JL. Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism. Am Heart J. 1991 Jan; 121(1 Pt 2):251-9; discussion 259-60. PMID: 1824647.
      View in: PubMed
    46. Pool JL. Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II. Clin Ther. 1990 Nov-Dec; 12(6):520-33. PMID: 2149674.
      View in: PubMed
    47. Pool JL, Lenz ML, Taylor AA. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations. J Hum Hypertens. 1990 Oct; 4 Suppl 3:23-33. PMID: 1979819.
      View in: PubMed
    48. Bradford RH, Shear CL, Chremos AN, Dujovne C, Franklin FA, Hesney M, Higgins J, Langendörfer A, Pool JL, Schnaper H, et al. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia. Am J Cardiol. 1990 Sep 18; 66(8):44B-55B. PMID: 2206036.
      View in: PubMed
    49. van Dixhoorn J, Duivenvoorden HJ, Staal HA, Pool J. Physical training and relaxation therapy in cardiac rehabilitation assessed through a composite criterion for training outcome. Am Heart J. 1989 Sep; 118(3):545-52. PMID: 2672755.
      View in: PubMed
    50. Pool JL, Taylor AA, Nelson EB. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension. Am J Med. 1989 Aug 16; 87(2A):57S-61S. PMID: 2569825.
      View in: PubMed
    51. Mallette LE, LeBlanc AD, Pool JL, Mechanick JI. Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronate. J Bone Miner Res. 1989 Apr; 4(2):143-8. PMID: 2499164.
      View in: PubMed
    52. Taylor AA, Davies AO, Mares A, Raschko J, Pool JL, Nelson EB, Mitchell JR. Spectrum of dysautonomia in mitral valvular prolapse. Am J Med. 1989 Mar; 86(3):267-74. PMID: 2919608.
      View in: PubMed
    53. Crawford ES, Coselli JS, Safi HJ, Martin TD, Pool JL. The impact of renal fusion and ectopia on aortic surgery. J Vasc Surg. 1988 Oct; 8(4):375-83. PMID: 3172375.
      View in: PubMed
    54. Pool JL, Nelson EB, Taylor AA. Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients. Am J Med. 1988 Sep 23; 85(3B):19-24. PMID: 2844082.
      View in: PubMed
    55. Cubeddu LX, Pool JL, Bloomfield R, Klotman PE, Pickering BI, Wombolt DG, Nelson EB, Halperin A. Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension. Am J Hypertens. 1988 Apr; 1(2):158-67. PMID: 2969740.
      View in: PubMed
    56. Goldfarb R, Pool JL, Wheeler T. Isolated renal artery dissection secondary to medial degeneration. J Urol. 1988 Feb; 139(2):346-7. PMID: 3339739.
      View in: PubMed
    57. Pool JL, Nelson EB, Taylor AA, Mitchell JR. Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension. Br J Clin Pract Suppl. 1987 Dec; 54:9-14. PMID: 2905162.
      View in: PubMed
    58. Simpson RK, Pool JL, Grossman RG, Rose JE, Taylor AA. Neurosurgical management of carotid sinus hypersensitivity. Report of three cases. J Neurosurg. 1987 Nov; 67(5):757-9. PMID: 3668646.
      View in: PubMed
    59. Schmedtje JF, Sax S, Pool JL, Goldfarb RA, Nelson EB. Localization of ectopic pheochromocytomas by magnetic resonance imaging. Am J Med. 1987 Oct; 83(4):770-2. PMID: 3674064.
      View in: PubMed
    60. Pool JL. Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension. Am J Cardiol. 1987 May 29; 59(14):46G-50G. PMID: 2884853.
      View in: PubMed
    61. Davies AO, Mares A, Pool JL, Taylor AA. Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity. Beta 2-adrenergic receptor supercoupling with desensitization on isoproterenol exposure. Am J Med. 1987 Feb; 82(2):193-201. PMID: 3028141.
      View in: PubMed
    62. Pool JL, Gennari J, Goldstein R, Kochar MS, Lewin AJ, Maxwell MH, McChesney JA, Mehta J, Nash DT, Nelson EB, et al. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension. J Cardiovasc Pharmacol. 1987; 9 Suppl 3:S36-42. PMID: 2442550.
      View in: PubMed
    63. Nelson EB, Pool JL, Taylor AA. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist. Clin Pharmacol Ther. 1986 Dec; 40(6):694-7. PMID: 2946507.
      View in: PubMed
    64. Nelson EB, Pool JL, Taylor AA. Pharmacology of angiotensin converting enzyme inhibitors. A review. Am J Med. 1986 Oct 31; 81(4C):13-8. PMID: 3022580.
      View in: PubMed
    65. Schwartz JB, Taylor A, Abernethy D, O'Meara M, Farmer J, Young J, Nelson E, Pool J, Mitchell JR. Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension. J Cardiovasc Pharmacol. 1985 Jul-Aug; 7(4):767-76. PMID: 2410720.
      View in: PubMed
    66. Taylor AA, Fennell WH, Ruud CO, Pool JL, Nelson EB, Ginos JZ, Mitchell JR. Propylbutyldopamine. Mechanism of blood pressure lowering in hypertensive patients. Hypertension. 1984 Mar-Apr; 6(2 Pt 2):I40-5. PMID: 6373598.
      View in: PubMed
    67. Simoons M, Lap C, Pool J. Heart rate levels and ventricular ectopic activity during cardiac rehabilitation. Am Heart J. 1980 Jul; 100(1):9-14. PMID: 7386369.
      View in: PubMed
    68. Taburet AM, Taylor AA, Mitchell JR, Rollins DE, Pool JL. Plasma concentrations of propranolol and 4-hydroxypropranolol in man measured by high pressure liquid chromatography. Life Sci. 1979 Jan 15; 24(3):209-17. PMID: 423699.
      View in: PubMed
    69. Taylor AA, Pool JL, Lake CR, Ziegler MG, Rosen RA, Rollins DE, Mitchell JR. Plasma norepinephrine concentrations: no differences among normal volunteers and low, high or normal renin hypertensive patients. Life Sci. 1978 May 1; 22(17):1499-510. PMID: 672409.
      View in: PubMed
    70. Mitchell JR, Taylor AA, Pool JL, Lake CR, Rollins DE, Bartter FC. Renin-aldosterone profiling in hypertension. Ann Intern Med. 1977 Nov; 87(5):596-312. PMID: 335942.
      View in: PubMed
    71. Pool JL. Muslin gauze in intracranial vascular surgery. Technical note. J Neurosurg. 1976 Jan; 44(1):127-8. PMID: 1244428.
      View in: PubMed
    72. Meilink-Hoedemaker LJ, Pool J, Muste-Heijns MM. A double-blind placebo-controlled cross-over study with lidoflazine (Clinium) in post-infarction patients. Acta Med Scand. 1976; 199(1-2):17-23. PMID: 766572.
      View in: PubMed
    73. Pool JL. Henry L. Heyl, 1906-1975. J Neurosurg. 1975 Jun; 42(6):625-7. PMID: 1095692.
      View in: PubMed
    74. Pool JL. Bifrontal craniotomy for anterior communicating artery aneurysms. J Neurosurg. 1972 Feb; 36(2):212-20. PMID: 5008735.
      View in: PubMed
    75. Pool JL. Excision of cerebral arteriovenous malformations. J Neurosurg. 1968 Sep; 29(3):312-21. PMID: 5684412.
      View in: PubMed
    76. Pool JL. Gliomas in the region of the brain stem. J Neurosurg. 1968 Aug; 29(2):164-7. PMID: 5673314.
      View in: PubMed
    77. McMurtry JG, Pool JL, Nova HR. The use of rheomacrodex in the surgery of intracranial aneurysms. J Neurosurg. 1967 Feb; 26(2):218-22. PMID: 6018581.
      View in: PubMed
    78. Pool JL, Colton RP. The dissecting microscope for intracranial vascular surgery. J Neurosurg. 1966 Sep; 25(3):315-8. PMID: 5921324.
      View in: PubMed
    79. Pool JL. Suboccipital surgery for acoustic neurinomas: advantages and disadvantages. J Neurosurg. 1966 Feb; 24(2):483-92. PMID: 5935378.
      View in: PubMed
    80. STEIN BM, LEEDS NE, TAVERAS JM, POOL JL. MENINGIOMAS OF THE FORAMEN MAGNUM. J Neurosurg. 1963 Sep; 20:740-51. PMID: 14184992.
      View in: PubMed
    81. POOL JL. Timing and techniques in the intracranial surgery of ruptured aneurysms of the anterior communicating artery. J Neurosurg. 1962 May; 19:378-88. PMID: 14487836.
      View in: PubMed
    82. POOL JL, POTANOS JN, KRUEGER EG. Osteomas and mucoceles of the frontal paranasal sinuses. J Neurosurg. 1962 Feb; 19:130-5. PMID: 14487830.
      View in: PubMed
    83. POOL JL. Treatment of arteriovenous malformations of the cerebral hemispheres. J Neurosurg. 1962 Feb; 19:136-41. PMID: 14487838.
      View in: PubMed
    84. RANSOHOFF J, POTANOS J, BOSCHENSTEIN F, POOL JL. Total removal of recurrent acoustic tumors. J Neurosurg. 1961 Nov; 18:804-10. PMID: 14490297.
      View in: PubMed
    85. POOL JL. Aneurysms of the anterior communicating artery. Bifrontal craniotomy and routine use of temporary clips. J Neurosurg. 1961 Jan; 18:98-112. PMID: 13737059.
      View in: PubMed
    86. POOL JL, KESSLER LA. Mechanism and control of centrally induced cardiac irregularities during hypothermia. I. Clinical observations. J Neurosurg. 1958 Jan; 15(1):52-64. PMID: 13492075.
      View in: PubMed
    87. POOL JL. Unilateral thoracic hyperhidrosis caused by osteoma of the tenth dorsal vertebra; case report. J Neurosurg. 1956 Jan; 13(1):111-5. PMID: 13286733.
      View in: PubMed
    88. POOL JL. The visceral brain of man. J Neurosurg. 1954 Jan; 11(1):45-63. PMID: 13131094.
      View in: PubMed
    89. GLUSMAN M, RANSOHOFF J, POOL JL, GRUNDFEST H, METTLER FA. Electrical excitability of the human motor cortex. I. The parameters of the electrical stimulus. J Neurosurg. 1952 Sep; 9(5):461-71. PMID: 12981568.
      View in: PubMed
    90. POOL JL, BRABSON JA. Pain in stimulating the distal segment of divided peripheral nerves. J Neurosurg. 1946 Nov; 3(6):468-73. PMID: 20279143.
      View in: PubMed
    91. SCARFF JE, POOL JL. Factors causing massive spasm following transection of the cord in man. J Neurosurg. 1946 Jul; 3:285-93. PMID: 20989177.
      View in: PubMed
    92. POOL JL, TURNER OA. Ependymoma of spinal cord; subtotal intramedullary removal from syringomyelic cavity. J Neurosurg. 1946 Jul; 3:348-51. PMID: 20989184.
      View in: PubMed
    93. POOL JL. Nerve stimulation in paraplegic patients by means of buried induction coil; preliminary report. J Neurosurg. 1946 May; 3:264-7. PMID: 21026951.
      View in: PubMed
    94. POOL JL. Electrospinogram (ESG); spinal cord action potentials recorded from a paraplegic patient. J Neurosurg. 1946 May; 3:192-8. PMID: 21026940.
      View in: PubMed
    POOL's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (341) concept(s)
    _
    Co-Authors Expand Description
    See all (9) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _